No Data
No Data
AstraZeneca, Daiichi Sankyo's Breast Cancer Drug Shows High-level Results in Late-stage Trial
Express News | AstraZeneca And Daiichi Sankyo's ENHERTU Plus Pertuzumab Demonstrates Statistically Significant PFS Benefit In Phase 3 Trial
Wayfinder Biosciences and Daiichi Sankyo Collaborate to Develop Novel RNA-targeting Therapies for Neurodegenerative Disease
Eli Lilly, Pfizer, Merck, AbbVie Shares After Trump Reiterates Tariff Threats on Drugs
AstraZeneca, Daiichi Sankyo Obtain EU Approval for Enhertu as Breast Cancer Treatment
Express News | Dogan Holding - Subsidiary Oncu Private Equity Enters a Share Transfer Agreement With Karel Elektronik and Ömer Tunc Akdeniz Regarding Acquisition and Transfer of Shares in Daiichi Elektronik